Search results
Liked by Neil Tabatznik From challenge to triumph, Happy's story is a journey of resilience and hope. One patient who came to us desperately needed cataract surgery on…
- 121
- Tshemba Foundation
- 134
Neil Tabatznik is a partner and co-founder of BIGC and a producer with a wealth of experience in the film and television industry. As a co-owner of the Blue Lake Media Fund, Neil has executive-produced a number of successful feature films including Steven Silver’s The Bang Bang Club and Alexander Payne’s Nebraska .
Our story starts in 2014, on a game drive in Hoedspruit, South Africa. Tshemba’s lead founder, Neil Tabatznik, was approached by the tracker of the drive to help with the slow build of his daughter’s satellite primary school. Neil agreed to build the entire school, but still wanted to do more.
At the time, The Tshemba Foundation approached the provincial health department, pitched the concept and offered to bring skilled medical volunteers to the region – and a partnership was born. The Foundation operates a medical volunteer programme that serves as a model of public-private partnership in the healthcare sector.
Mar 29, 2024 · Others, like Neil Tabatznik of Blue Ice Docs, helped grow Hot Docs’ film funds with the Hot Docs–Blue Ice Fund supporting African talent. “There were no other outlets where these funders could direct their focus and energies toward African filmmakers living and working on the continent,” explains Radshaw.
Tshemba welcomed its first volunteer in 2017, but our story truly begins back in 2014 on a game drive in Hoedspruit, South Africa. Our lead founder, Neil Tabatznik, was approached by the tracker of the drive to help with the slow build of his daughter’s satellite primary school. Neil agreed, but still wanted to do more.
People also ask
Who is Neil Tabatznik?
Who are Robin Smith & Neil Tabatznik?
Who is David Tabatznik?
Who is Mark Tabatznik?
Neil Tabatznik, Acting Chairman. Neil has been with CardioGenics since 2003. He is the Chairman, CEO of Arrow Pharmaceuticals Inc. Arrow Pharmaceuticals is part of a global generic drug company established in 2000, and has seen rapid growth from 0 to 700 million in 8 years.